- €2.93bn
- €3.11bn
- €1.46bn
Brief: Virbac Acquires Felanorm In a Deal Valued at 100 million pounds
Brief: Virbac Acquires Thyronorm
Kepler upgrades Virbac to 'buy' on strong outlook
Bernstein starts Virbac at 'market-perform' on future margin growth
Animal drugs maker Virbac jumps on 'strong' Q3 momentum, FY outlook hike
Brief: Virbac Expects FY Revenue Growth Between 5-7.5%
Europe Research Roundup: Derwent London, Embla Medical, Virbac
Virbac tracks worst day in 11 months on H1 marred by one-offs, costs
Brief: Virbac Says US Tariffs Impacts Of Eur 4 Mln On FY Basis
Virbac edges up on 'solid' H1 sales
French and Benelux stocks-Factors to watch on Thursday
Brief: Virbac Q2 Revenue EUR 363.1 Mln
Oddo BHF ups Virbac on solid fundamentals, improving momentum
Brief: Virbac To Appoint Paul Martingell As CEO
French and Benelux stocks-Factors to watch
Brief: Virbac Q1 Revenue EUR 375.2 Million
Brief: Virbac Q1 2025 Revenue EUR 375.2 Mln
Virbac jumps on Stifel upgrade to 'buy', cheap stock price
French and Benelux stocks-Factors to watch